In BRAF-mutant melanoma cells, BRN2 transcriptionally represses the expression of PDE5A (cyclic nucleotide phosphodiesterase 5A), leading to increased cGMP levels and phosphorylation of MYL2 (myosin light chain 2) and consequently increased invasion [104]. Here, MYL2 is linked to melanoma.